# OnCo record mabwell-shanghai-bioscience (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mabwell-shanghai-bioscience/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mabwell-shanghai-bioscience" ;
  schema:name "Mabwell (Shanghai) Bioscience"@en ;
  schema:alternateName "Mabwell (Shanghai) Bioscience Co., Ltd."@en ;
  schema:description "Mabwell (Shanghai) Bioscience is a China-based biotechnology company running 11 late-stage cancer trials of Toripalimab (JS001 ) and JS207 in bladder & urothelial cancer, cervical cancer and colorectal cancer."@en ;
  schema:url <https://onco.cc/companies/mabwell-shanghai-bioscience/>, <https://www.mabwell.com/en/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.mabwell.com/en/>, <https://clinicaltrials.gov/search?lead=Mabwell%20(Shanghai)%20Bioscience%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/tnbc/> ;
  onco:trials <https://onco.cc/trials/nct06823427/>, <https://onco.cc/trials/nct07314723/>, <https://onco.cc/trials/nct06079112/>, <https://onco.cc/trials/nct06592326/>, <https://onco.cc/trials/nct06492005/>, <https://onco.cc/trials/nct07466160/>, <https://onco.cc/trials/nct06196736/>, <https://onco.cc/trials/nct06692166/>, <https://onco.cc/trials/nct07216560/>, <https://onco.cc/trials/nct07265622/>, <https://onco.cc/trials/nct05990452/> .